JP2023107883A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023107883A5 JP2023107883A5 JP2023096692A JP2023096692A JP2023107883A5 JP 2023107883 A5 JP2023107883 A5 JP 2023107883A5 JP 2023096692 A JP2023096692 A JP 2023096692A JP 2023096692 A JP2023096692 A JP 2023096692A JP 2023107883 A5 JP2023107883 A5 JP 2023107883A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- composition
- surgery
- glp
- parenteral nutrition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762582055P | 2017-11-06 | 2017-11-06 | |
| US62/582,055 | 2017-11-06 | ||
| JP2020526107A JP7296958B2 (ja) | 2017-11-06 | 2018-11-05 | 手術前、手術中または手術後に投与するためのglp-2類似体及びglp-2ペプチボディ |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020526107A Division JP7296958B2 (ja) | 2017-11-06 | 2018-11-05 | 手術前、手術中または手術後に投与するためのglp-2類似体及びglp-2ペプチボディ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023107883A JP2023107883A (ja) | 2023-08-03 |
| JP2023107883A5 true JP2023107883A5 (cg-RX-API-DMAC7.html) | 2024-03-06 |
| JP7752152B2 JP7752152B2 (ja) | 2025-10-09 |
Family
ID=66332372
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020526107A Active JP7296958B2 (ja) | 2017-11-06 | 2018-11-05 | 手術前、手術中または手術後に投与するためのglp-2類似体及びglp-2ペプチボディ |
| JP2023096692A Active JP7752152B2 (ja) | 2017-11-06 | 2023-06-13 | 手術前、手術中または手術後に投与するためのglp-2類似体及びglp-2ペプチボディ |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020526107A Active JP7296958B2 (ja) | 2017-11-06 | 2018-11-05 | 手術前、手術中または手術後に投与するためのglp-2類似体及びglp-2ペプチボディ |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11660328B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3706774A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7296958B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102825098B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111629745A (cg-RX-API-DMAC7.html) |
| AR (1) | AR113835A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018360744A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112020008936A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3079523A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL274098B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2020004620A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI911137B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019090209A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202002080B (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018321841A1 (en) * | 2017-08-22 | 2020-02-20 | Shire-Nps Pharmaceuticals, Inc. | GLP-2 fusion polypeptides and uses for treating and preventing gastrointestinal conditions |
| WO2020086741A1 (en) * | 2018-10-24 | 2020-04-30 | Shire-Nps Pharmaceuticals, Inc. | Glp-2 fusion polypeptides and uses for treating and preventing gastrointestinal conditions |
| SG11202111312UA (en) | 2019-06-14 | 2021-12-30 | Zealand Pharma As | Pharmaceutical parenteral composition of dual glp1/2 agonist |
| JP2022552655A (ja) | 2019-10-07 | 2022-12-19 | キャリーオペ,インク. | Gpr119アゴニスト |
| MX2022010548A (es) | 2020-02-28 | 2022-09-23 | Kallyope Inc | Agonistas de gpr40. |
| EP4126003A1 (en) * | 2020-03-30 | 2023-02-08 | Zealand Pharma A/S | Glp-1/glp-2 dual agonists |
| MX2022014505A (es) | 2020-05-19 | 2022-12-13 | Kallyope Inc | Activadores de la ampk. |
| CA3183575A1 (en) | 2020-06-26 | 2021-12-30 | Iyassu Sebhat | Ampk activators |
| WO2021263040A1 (en) * | 2020-06-26 | 2021-12-30 | Shire-Nps Pharmaceuticals, Inc. | Stable peptibody formulations |
| CN115636876A (zh) * | 2021-07-20 | 2023-01-24 | 重庆派金生物科技有限公司 | 胰高血糖素样肽-2突变体的定向化学偶联物及其应用 |
| CN117467025B (zh) * | 2023-12-28 | 2024-04-16 | 上海鼎新基因科技有限公司 | 一种抗vegf和补体双功能融合蛋白及其应用 |
| WO2025181330A1 (en) * | 2024-02-29 | 2025-09-04 | Vectivbio Ag | Dosage regimens for glucagon-like peptide 2 (glp-2) analogs |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1809318T3 (da) * | 2004-11-01 | 2013-09-08 | Nps Pharma Inc | Behandling af korttarmssyndrom-patienter med tyktarmskontinuitet |
| JP2009510999A (ja) * | 2005-07-29 | 2009-03-19 | エーエムプロテイン コーポレイション | キメラ治療剤 |
| AU2006321743A1 (en) * | 2005-10-24 | 2007-06-14 | Centocor, Inc. | GLP-2 mimetibodies, polypeptides, compositions, methods and uses |
| US7812121B2 (en) * | 2006-08-31 | 2010-10-12 | Baker Audrey E | GLP-2 mimetibodies, polypeptides, compositions, methods and uses |
| JP2008247789A (ja) * | 2007-03-30 | 2008-10-16 | Kissei Pharmaceut Co Ltd | クローン病に伴う腸管狭窄の進展抑制用医薬組成物 |
| ES2687651T3 (es) * | 2011-09-12 | 2018-10-26 | Amunix Operating Inc. | Composiciones de péptido-2 similar a glucagón y métodos para producir y usar los mismos |
| US9458214B2 (en) * | 2011-09-26 | 2016-10-04 | Novartis Ag | Dual function fibroblast growth factor 21 proteins |
| KR101895047B1 (ko) * | 2011-12-30 | 2018-09-06 | 한미사이언스 주식회사 | 면역글로불린 단편을 이용한 위치 특이적 글루카곤 유사 펩타이드-2 약물 결합체 |
| EA028929B1 (ru) | 2012-05-03 | 2018-01-31 | Зилэнд Фарма А/С | Аналоги глюкагоноподобного пептида-2 (glp-2) |
| US10137170B2 (en) * | 2013-12-20 | 2018-11-27 | Indiana University Research And Technology Corporation | Lipidated incretin receptor ligand human immunoglobulin Fc-region fusion polypeptides |
| KR101825048B1 (ko) | 2014-12-31 | 2018-02-05 | 주식회사 제넥신 | GLP 및 면역글로불린 하이브리드 Fc 융합 폴리펩타이드 및 이의 용도 |
-
2018
- 2018-11-05 CN CN201880071791.3A patent/CN111629745A/zh active Pending
- 2018-11-05 CA CA3079523A patent/CA3079523A1/en active Pending
- 2018-11-05 US US16/761,606 patent/US11660328B2/en active Active
- 2018-11-05 WO PCT/US2018/059175 patent/WO2019090209A1/en not_active Ceased
- 2018-11-05 KR KR1020207013387A patent/KR102825098B1/ko active Active
- 2018-11-05 JP JP2020526107A patent/JP7296958B2/ja active Active
- 2018-11-05 IL IL274098A patent/IL274098B2/en unknown
- 2018-11-05 BR BR112020008936-2A patent/BR112020008936A2/pt unknown
- 2018-11-05 EP EP18872377.9A patent/EP3706774A4/en active Pending
- 2018-11-05 AU AU2018360744A patent/AU2018360744A1/en not_active Abandoned
- 2018-11-05 MX MX2020004620A patent/MX2020004620A/es unknown
- 2018-11-06 AR ARP180103232A patent/AR113835A1/es unknown
- 2018-11-06 TW TW107139266A patent/TWI911137B/zh active
-
2020
- 2020-05-04 ZA ZA2020/02080A patent/ZA202002080B/en unknown
-
2023
- 2023-06-13 JP JP2023096692A patent/JP7752152B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274098B2 (en) | Glp-2 analogs and peptibodies for administration before during, or after surgery | |
| Lever | Methotrexate and prednisone in pemphigus vulgaris: therapeutic results obtained in 36 patients between 1961 and 1970 | |
| Buchwald et al. | Ileal bypass in patients with hypercholesterolemia and atherosclerosis: preliminary report on therapeutic potential | |
| JP2021502389A5 (cg-RX-API-DMAC7.html) | ||
| Halloun et al. | Bariatric surgery in adolescents with obesity: long-term perspectives and potential alternatives | |
| JP2019530648A5 (cg-RX-API-DMAC7.html) | ||
| Hermann | Acquired Brown's syndrome of inflammatory origin: response to locally injected steroids | |
| Sticherling | Systemic sclerosis–the dermatological perspective | |
| Han et al. | Management of eosinophilic granuloma occurring in the appendicular skeleton in children | |
| Sharma et al. | Primary spinal epidural Ewing's sarcoma | |
| Shah et al. | Sinus node dysfunction secondary to hyperparathyroidism | |
| Ozaki et al. | Manifestation of latent left ventricular outflow tract obstruction caused by acute myocardial infarction: an important complication of acute myocardial infarction | |
| Hanna et al. | Efficacy and complications of intravesical BCG in immunocompromised patients | |
| CN104815090B (zh) | 一种治疗闭合性损伤的外用制剂及其制备方法 | |
| Katsube et al. | Interposition grafting of collagen-gelatin sponge impregnated with basic fibroblast growth factor in primary palatoplasty | |
| Kaddioui et al. | Pansclerotic morphea: a historical case in children | |
| Greenberg et al. | Current and emerging multiple sclerosis therapeutics | |
| Akhyar et al. | Clinical features and evaluation of systemic sclerosis: A dermatology-based case series | |
| Elbrønd et al. | Circinoma Linguae: A series of 96 patients | |
| Javier et al. | Skeletal recovery from hepatitis C-associated osteosclerosis (HCAO) following antiviral treatment | |
| Dennie et al. | A phase I study of capecitabine, oxaliplatin, and lapatinib in metastatic or advanced solid tumors | |
| Hendi et al. | Advanced age is a strongly benefit for patients undergoing laparoscopic pancreaticodoudenectomy, comparative study | |
| Di Nuzzo et al. | Safety of etanercept treatment in psoriatic patients with chronic hepatitis c infection: Preliminary data from a clinical and virological study in five patients | |
| Kądziołka et al. | Systemic Sclerosis–A Diagnostic Challenge or a Clinically Controllable Disease? | |
| Hrkač et al. | Early cyclophosphamide treatment in new-onset progressive cutaneous systemic sclerosis–a case report and literature review |